Portfolio Sees Dishman Exit in a Hurry as Customer Clovis Loses 70% Market Cap in the US
In a rapid descent into madness, Dishman Pharma fell over 12% today. It wasn’t a pretty sight, as the stock kept tanking through the day, while we tried ...